Enlivex Pharmaceuticals
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.enlivexpharm.comRevenue
$5.2 MillionIndustry
About Enlivex Pharmaceuticals
Is Enlivex Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Enlivex Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Enlivex Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Enlivex Pharmaceuticals has new funding data
Click to see if Enlivex Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Enlivex Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Enlivex Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Enlivex Pharmaceuticals
Check out if Enlivex Pharmaceuticals is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Enlivex Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Enlivex Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Enlivex Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Enlivex Pharmaceuticals.
Enlivex Pharmaceuticals Tech Stack
A closer look at the technologies used by Enlivex Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enlivex Pharmaceuticals
Enlivex specializes in harnessing the natural healing power of macrophages to treat inflammatory diseases through their proprietary cell therapy platform, Allocetra. This innovative therapy offers flexible administration options and has been clinically tested with over 150 patients, showing no serious adverse events. Enlivex is exploring Allocetra... Read More